7 studies found for:    DERMATITIS, ATOPIC, 6
Show Display Options
Rank Status Study
1 Not yet recruiting A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
Condition: Dermatitis, Atopic
Interventions: Other: Individual session therapeutic education;   Other: Phone Call
2 Enrolling by invitation A Study to Assess the Long-term Safety of Dupilumab (REGN668/SAR231893) Administered in Patients 6 to <18 Year of Age With Atopic Dermatitis (AD)
Condition: Atopic Dermatitis
Intervention: Drug: Dupilumab
3 Active, not recruiting A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
Condition: Atopic Dermatitis
Intervention: Drug: Dupilumab
4 Terminated Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%
Condition: Atopic Dermatitis
Interventions: Drug: MRX-6;   Other: Placebo
5 Completed Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
Condition: Dermatitis, Atopic
Intervention: Drug: WBI-1001
6 Not yet recruiting Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
Condition: Atopic Dermatitis
Interventions: Drug: Probiatop;   Drug: Placebo
7 Terminated Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Condition: Atopic Dermatitis
Interventions: Drug: LEO 29102;   Drug: LEO 29102 Cream Vehicle

Indicates status has not been verified in more than two years